- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06891911
Dagligvarer for innbyggere i det sørøstlige USA for å stoppe hypertensjon (GoFreshSE)
GoFreshSE is a randomized control trial, testing the effects of a home-delivered, dietitian-assisted, DASH-patterned grocery intervention on blood pressure in adults with high blood pressure in Florida, Georgia, and Tennessee.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Hypertension (HTN) affects half of US adults and is one of the most important modifiable risk factors for cardiovascular disease (CVD) and death.
The DASH diet is a proven strategy for lowering blood pressure in adults. Our proposed clinical trial will evaluate the effectiveness of a scalable solution: home-delivered, low-sodium groceries aligned with the DASH dietary pattern and ordered with dietitian assistance via a virtual supermarket, in reducing blood pressure.
Participants will be assigned to one of two 1-month long interventions: (1) dietitian-assisted, DASH-patterned, home-delivered groceries ordered weekly through Amazon Fresh (or Whole Foods) over 4 weeks or (2) self-directed grocery shopping (monthly stipend and DASH diet brochure) (referent).
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02215
- Beth Israel Deaconess Medical Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Resting systolic blood pressure of 120 to <160 mm Hg and diastolic blood pressure <110 mm Hg
- Resident of Florida, Georgia, and Tennessee
- Able to receive home-delivered groceries or pick them up at a convenient location and willing to eat only the groceries provided over a 4-week period
- Have access to refrigeration, cooking appliances, and Wi-Fi/cellular service
- Have access to mobile device or computer to be able to conduct grocery orders via video conference and send/receive text messages
- Willing and able to complete required measurement procedures
- Able to provide consent for the study
- Has access to a primary care team, urgent care center, or emergency room the study team can refer to for follow up care if warranted during the study
Exclusion Criteria:
A. Laboratory Exclusions:
- Serum potassium ≥5.4 mmol/L or <3.5 mmol/L
- Estimated glomerular filtration rate (eGFR) <30 mL/min per 1.73 m^2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
- Hemoglobin A1c ≥6.5%
B. Medication Exclusions:
Unstable doses (i.e. a change in the 6 months prior to screening or randomization or planning to start within study period) of the following:
- GLP-1 and dual GLP-1/GIP receptor agonists
- Anti-hypertension medications
- Sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Glucose lowering medications
Use of any of the following medications:
- Potassium supplement, except if part of a multivitamin
- Warfarin (Coumadin)
- Chronic oral corticosteroid (intermittent use is okay)
- Weight loss medications (non-GLP-1 receptor agonists)
- Sulfonylurea or any insulin use
Any medication not compatible with participation as determined by the investigators
C. Physical Exclusions:
- Systolic blood pressure: <120 or ≥160 mm Hg or diastolic blood pressure ≥110 mm Hg
- Arm circumference >52 cm (or the upper limit of the validated BP device)
D. Medical History Exclusions:
- Self-reported weight loss or gain of 15 pounds during prior 2 months
- Active cardiovascular disease or any event in the prior 6 months, including coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction (MI), cerebrovascular accident (CVA), or congestive heart failure (CHF) exacerbation requiring hospital admission
- Cancer diagnosis or treatment in the last 2 years (non-melanoma skin cancer or localized breast or prostate or bladder cancer not requiring systemic therapy is acceptable)
- Gastrointestinal surgery or history that affects nutrition absorption or requires a specific diet that will deter DASH diet adherence
- Pregnancy or lactation or planned pregnancy during the study period
- Any emergency department (ED) visit for asthma or chronic obstructive pulmonary disease (COPD) in the last 6 months
- Hypoglycemia hospitalization in the last 12 months
- Any other serious illness or condition not compatible with participation as determined by the investigators
E. Lifestyle and Other Exclusions:
- Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence
- Consumption of more than 14 alcoholic drinks per week or consumption of more than 6 drinks on one or more occasion per week
- Active substance use disorder that would interfere with participation
- Extreme food insecurity
- Participation in or planning to start weight loss program
- Current participation in another clinical trial that could interfere with the study protocol
- Anticipated change in residence outside of eligible states prior to the end of the study
- Families with more than 6 adults at dinner time (children count as half an adult)
F. Investigator discretion
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Dietitian-Assisted DASH Groceries
Participants will order groceries sufficient to meet their caloric needs each week for 4 weeks with the assistance of a dietitian/nutrition interventionist. Groceries will be delivered to participants' homes or picked up at a convenient location. The dietitian/nutrition interventionist will provide brief educational content at the time of food delivery. Orders will be placed via phone or through virtual counseling sessions. |
The DASH ("Dietary Approaches to Stop Hypertension"), is a healthy dietary pattern that lowers blood pressure without reducing weight. The DASH diet emphasizes fruits, vegetables, and low-fat dairy products; includes whole grains, poultry, fish, and nuts; and is reduced in red meat, sweets, and sugar-containing beverages. Intervention Phase: This intervention is a weekly, 4-week DASH dietary intervention. A dietitian will assist participants in ordering groceries in a pattern consistent with the DASH diet to be delivered to their homes. The quantity of groceries will be based on participant Calorie needs and family size. |
|
Aktiv komparator: Self-directed shopping
Participants will receive a stipend and some basic information about healthy eating. The stipend is not restricted to foods. |
Intervention Phase: Participants will receive some basic information on healthy eating and a stipend during the 4-week intervention period. They are permitted to use the stipend however they choose and will not be asked about how they spent these funds. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-measured systolic blood pressure
Tidsramme: Measured before and after the 4-week intervention
|
This entails 4 measurements, 2 in the morning and 2 in the evening, over a 7 day period (at least 3 concurrent days is acceptable for analysis). |
Measured before and after the 4-week intervention
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-measured diastolic blood pressure
Tidsramme: Measured before and after the 4-week intervention
|
This entails 4 measurements, 2 in the morning and 2 in the evening, over a 7 day period (at least 3 concurrent days is acceptable for analysis). |
Measured before and after the 4-week intervention
|
|
Seated systolic and diastolic blood pressure (technician-measured)
Tidsramme: Measured before and after the 4-week intervention
|
Seated systolic and diastolic blood pressure measured by a technician in participants' homes, using the office blood pressure device. |
Measured before and after the 4-week intervention
|
|
Body Mass Index (BMI)
Tidsramme: Height is measured before the intervention. Weight is measured before and after the 4-week intervention.
|
At home measurement based on height and weight measured by a technician via a stadiometer and scale. |
Height is measured before the intervention. Weight is measured before and after the 4-week intervention.
|
|
24-hour dietary recall
Tidsramme: Measured before and after the 4-week intervention
|
Assessed via self-administered questionnaire using the Automated Self-Administered 24-Hour Dietary Recall (ASA24). |
Measured before and after the 4-week intervention
|
|
Spot urine sodium/potassium ratio
Tidsramme: Measured before and after the 4-week intervention
|
Measured in urine collected at the participants' homes. |
Measured before and after the 4-week intervention
|
|
Lipids
Tidsramme: Measured before and after the 4-week intervention
|
Measured in fasted serum specimens collected during phlebotomy. Includes total cholesterol, high density lipoprotein cholesterol, derived low density lipoprotein cholesterol, and triglycerides |
Measured before and after the 4-week intervention
|
|
Fasting glucose
Tidsramme: Measured before and after the 4-week intervention
|
Measured in blood as part of a basic metabolic panel |
Measured before and after the 4-week intervention
|
|
Serum potassium
Tidsramme: Measured before and after the 4-week intervention
|
Measured in blood as part of a basic metabolic panel |
Measured before and after the 4-week intervention
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
General Health Status
Tidsramme: Measured before and after the 4-week intervention
|
Single General Health Status Question: "Would you say that in general your health is excellent, very good, good, fair, or poor?" |
Measured before and after the 4-week intervention
|
|
Financial strain
Tidsramme: Measured before and after the 4-week intervention
|
We will ask the following questions: How often does this describe you? I don't have money to pay my bills (including food, housing, medical care or heating). Never / Rarely / Sometimes / Often / Always |
Measured before and after the 4-week intervention
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2025P000102
- GRT67144 (Annet stipend/finansieringsnummer: American Heart Association)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .